Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Public ClinicalTrials.gov record NCT03381625. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, placebo-controlled Phase 2 trial consisting of up to 300 subjects with either psoriasis or atopic dermatitis. In this trial BMX-010 will be topically applied twice daily for up to 28 days.
Study identification
- NCT ID
- NCT03381625
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 139 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2018 (Actual)
- Primary completion
- Jul 24, 2021 (Actual)
- Completion
- Jul 24, 2021 (Actual)
- Last update posted
- Oct 5, 2021
2018 – 2021
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Encino Research Center | Encino | California | 91436 | — |
| Apex Dermatology | Denver | Colorado | 80230 | — |
| Colorado Skin Care | Englewood | Colorado | 80113 | — |
| AboutSkin Dermatology & DermSurgery | Greenwood Village | Colorado | 80111 | — |
| Ciocca Dermatology | Miami | Florida | 33173 | — |
| Dawes Fretzin Dermatology Group | Indianapolis | Indiana | 46256 | — |
| Juva Skin & Laser Center | New York | New York | 10022 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
| Dermatology Associates of Nashville | Knoxville | Tennessee | 37917 | — |
| Presicion Research Institute | Houston | Texas | 77029 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03381625, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03381625 live on ClinicalTrials.gov.